The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Amgen Inc  (AMGN) Trade Now »     Rate AMGN  -  Discuss AMGN  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks
This Quarter's Sentiment:
All:
85.5%
Top:
100.0%
Rate AMGN:


Bull or Bear
        

AMGN: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

My target for AMGN is $69 Graphic_rating_buy AMGN
Lee2004_11_26
55%
By  Moneycrackerlee   (-1.89%  risk: aggressive)  09/05/07 Comment


AMGN is a BUY Graphic_rating_buy AMGN
Lee2004_11_26
55%
By  Moneycrackerlee   (-1.89%  risk: aggressive)  08/15/07 Comment


Bottom Feeder Graphic_rating_buy AMGN
12%
By  Shaun Holt   (-28.51%  risk: aggressive)  08/11/07 Comment


Beaten Up Biotech Graphic_rating_buy AMGN
 5 %
By  Michael M   (-19.48%  risk: aggressive)  07/12/07 Comment


Biotech Leader Graphic_rating_buy AMGN
Tammikuu-1
70%
By  Matias Klein   (+5.74%  risk: aggressive)  07/11/07 Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.44% 381
2 18.14 +71.24% 211
3 17.66 +25.60% 55
4 13.47 +14.32% 62
5 12.13 +74.22% 40


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on AMGN

Visit streetinsider.com


Discussion Wall + Add  

amritadas   (+0.00%)
A FREE report on the approval of a new Gout Drug An upcoming treatment by a small cap company for Gout to face FDA decision on approval shortly. Gout has traditionally been a difficult disease to tre
+   0 replies

amritadas   (+0.00%)
A FREE report on the approval of a new Gout Drug FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by th...
+   0 replies

amritadas   (+0.00%)
Free report on upcoming FDA panel decision of Corvu.. FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by th...
+   0 replies

The
Edward Gardere   (-0.89%  risk: moderate)
Portfolio results thru 8/8/08 Portfolio at www.updown.com - started 1/11/08 9.8% return includes dividends and commission. Started socialpicks on 6/30. some stocks here are not in...
+   2 replies

The
Edward Gardere   (-0.89%  risk: moderate)
Stock update and watch list 7/29/08 Due to difficulties understanding the socialpicks system regarding changing rating from buy to hold and thus resetting the performance, I wanted to sum...
+   5 replies


More Resources

Graphic_arrow1 About Amgen Inc - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch